Methods of Treating Apoptosis and Altering Programmed Cell Death
AssigneeMyMD Pharmaceuticals, Inc.
InventorJonnie R. Williams
Life of this patent
Estimating the term…
Abstract
In one aspect, a method of altering programmed cell death includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In other aspects, isomyosmine is administered to treat a wound, hemochromatosis, traumatic brain injury, or disorders associated with chronic oxidative stress. In other aspects, isomyosmine is administered to increase blood oxygen saturation levels.
Claims14
A method of altering programmed cell death (apoptosis) comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
A method of treating a wound or a disorder selected from the group consisting of hemochromatosis, traumatic brain injury, major depression, minor depression, atypical depression, dysthymia, attention deficit disorder, hyperactivity, conduct disorder, narcolepsy, social phobia, obsessive compulsive disorder, atypical facial pain, eating disorders, drug withdrawal syndromes and drug dependence disorders, melancholia, panic disorder, bulimia, anergic depression, treatment resistant depression, headache, chronic pain syndrome, generalized anxiety disorder, toxemia of pregnancy, coronary artery disease, sickle cell disease, idiopathic pulmonary fibrosis, and endometriosis, the method comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
A method of increasing blood oxygen saturation levels comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
A method of mitigating the effects of space travel comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.